9th Annual Cell and Gene Therapy Symposium

Centre for Stem Cell Research (a unit of inStem, Bengaluru), Christian Medical College Campus, Vellore

CGTS 2018

3rd Annual Cell and Gene Therapy Symposium

6-7 September, 2018

Scientific Program

DAY-1: THURSDAY, 06TH SEPTEMBER, 2018

9:30 to 10:00AM: REGISTRATION 

10:00 to 10:15AM

 

10:15 to 10:20AM

 

10:20 to 10:25AM

 

 Welcome and introductory remarks – Director / Principal, CMC, Vellore

 

Address by Dr. Renu Swarup, Secretary, Department of Biotechnology (DBT), Govt. of India

 

Address by Dr. Balram Bhargava, Secretary, Department of Health Research (DHR), Govt. of India & Director General, Indian Council of Medical Research (ICMR)
Session-1:  IMMUNE CELL THERAPY
10:25 to 10:30AM Introduction to the session
10:30 to 11:00AM Strategies to Drive CAR-T Cells into Solid Tumors Avery Posey

Parker Institute for Cancer Immunotherapy,

University of Pennsylvania, USA
11:00 to 11:30AM CAR T-cells against lymphoid cells: Hurdles in transitioning from B cell to T cell malignancies Trent Spencer

Emory University

School of Medicine, USA
11:30 to 12:00PM Indigenous CAR T cell technology development: Present and future in India Rahul Purwar

Indian Institute of Technology Bombay, India
12:00 to 1:00PM Lunch
Session-2:  CELL AND GENE THERAPY IN NEUROLOGICAL DISORDERS
1:00 to 1:05PM Introduction to the session
1:05 to 1:35PM Next-generation gene therapy products for Duchenne muscular dystrophy and other muscle disorders Marinee Chuah

Free University of Brussels & University of Leuven, Belgium
1:35 to 2:05PM Stem cell therapy for stroke recovery: Hope or hype? Padma Srivastava

All India Institute of Medical Sciences, New Delhi, India
2:05 to 2:35PM Gene therapy for Duchenne muscular dystrophy (DMD) – The India Scenario Arun Shastry

Dystrophy Annihilation Research Trust, India
2:35 to 3:05PM Packing in portions: Dual vector strategies to expand AAV vector capacity Arkasubhra Ghosh

Narayana Nethralaya Foundation, India

Session-3: NON-VIRAL GENE TRANSFER TECHNOLOGY
3:05 to 3:10PM Introduction to the session
 

3:10 to 3:40PM

 Design and delivery of messenger RNA based-therapeutics Chantal Pichon

Center for Molecular Biophysics-CNRS, University of Orléans, France
3:40to 4:10PM siRNA for therapeutic gene regulation Narendra Chirmule

Biocon Research Limited, India
4:10 to 4:40PM Novel strategies for cationic lipid enabled CRISPR/Cas9 based genome editing in hematopoietic cells Srujan Marepally

Centre for Stem Cell Research, India
4:40 to 5:05PM Tea Break / CSCR Posters
Session-4: TECHNOLOGY ADVANCES
5:05 to 5:10PM Introduction to the session  
5:10 to 5:40PM New and improved AAV vectors Arun Srivastava

University of Florida

College of Medicine, USA
5:40 to 6:10PM Enabling the CAR-T revolution:  Clinically compliant systems for the processing and release of CAR-T products Roland Leathers

Thermo Fisher Scientific, Switzerland
6:10 to 6:40PM Automated manufacturing of cell therapy products with CliniMACS Prodigy system – CAR T cells and more Ryan Wu Feiyi

Miltenyi Biotec Asia Pacific, Singapore
KEY NOTE ADDRESS
6:40 to 6:45PM Introduction
6:45 to 7:45PM Gene therapy – From promise to reality Trent Spencer

Emory University

School of Medicine, USA
7:45PM onwards Dinner

DAY-2: FRIDAY, 07TH SEPTEMBER, 2018

Session-5: GENE THERAPY
8:30 to 8:35AM Introduction to the session
8:35 to 9:05AM Gene replacement vs gene editing for gene therapy of hemophilia: Promises and challenges Thierry VandenDriessche

Free University of Brussels & University of Leuven, Belgium
9:05 to 9:35AM Assessing genotoxicity and efficacy of zinc finger nuclease modification of primary human and canine cells for FVIII secretion Jaichandran Sivalingam

National Cancer Centre & Agency for Science, Technology and Research, Singapore
9:35 to 10:05AM Gene therapy for hemophilia Alok Srivastava

Centre for Stem Cell Research & Christian Medical College, Vellore, India
10:05 to 10:35AM Gene therapy of liver cancer with AAV3 vectors Arun Srivastava

University of Florida

College of Medicine, USA
10:35 to 11:00AM Tea Break / CSCR Posters
 

 

Session-6: GENE EDITING
11:00 to 11:05AM Introduction to the session
11:05 to 11:35AM Gene editing approaches for treatment of beta-hemoglobinopathies Saravanabhavan Thangavel

Centre for Stem Cell Research, India
11:35 to 12:05PM Therapeutic genome editing for beta-hemoglobinopathies Mohankumar Murugesan

Centre for Stem Cell Research, India
12:05 to 12:30PM A proposed framework for governing human gene editing in India Shambhavi Naik

Takshashila Institution, India
12:30 to 1:30PM Lunch
Session-7: APPLICATIONS OF iPSC TECHNOLOGY
1:30 to 1:35PM Introduction to the session
1:35 to 2:05PM Translational applications of pluripotent stem cells Shaji Velayudhan

Centre for Stem Cell Research & Christian Medical College, Vellore, India
2:05 to 2:35PM iPSCs for ocular regeneration: Progress so far, challenges and way forward Indumathi Mariappan

L V Prasad Eye Institute, India
2:35 to 3:05PM Developing pluripotent stem cells for clinical applications Glyn Stacey

International Stem Cell Banking Initiative & SSC Bio Ltd., UK
3:05 to 3:15PM Conclusion remarks

Gallery

[soliloquy id=”431″]